MAPT and Alzheimer disease: Impaired glucose uptake and metabolism have been shown to result in decreased levels of O-linked N-acetylglucosamine (O-GlcNAc) and subsequent hyperphosphorylation of tau protein, leading to the formation of neurofibrillary tangles and neuronal degeneration in the brains of AD patients.